Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA CEO Selection Day Nears Now That Election Day Is Past

This article was originally published in The Pink Sheet Daily

Executive Summary

Trade association board is expected to finalize choice to succeed CEO Alan Holmer during Nov. 11-12 strategy session. Rep. Billy Tauzin (R-La.) is still viewed as the likely pick.

You may also be interested in...



PhRMA CEO Succession Appears Set: Timing Not Yet Final

The Pharmaceutical Research & Manufacturers of America is understood to have finalized its plans to name retiring Rep. Billy Tauzin (R-La.) as its next CEO

PhRMA CEO Succession Appears Set: Timing Not Yet Final

The Pharmaceutical Research & Manufacturers of America is understood to have finalized its plans to name retiring Rep. Billy Tauzin (R-La.) as its next CEO

PhRMA Starts Over In CEO Search After Tauzin Negotiations End

Louisiana Republican breaks off negotiations with trade association amid negative media attention. Rep. Joe Barton will take the helm of the Energy & Commerce Committee.

Topics

UsernamePublicRestriction

Register

LL035386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel